510(k) K053074

N ANTISERA TO HUMAN CERULOPLASMIN by Dade Behring, Inc. — Product Code DDB

K053074 is an FDA 510(k) premarket notification submitted by Dade Behring, Inc. for the device "N ANTISERA TO HUMAN CERULOPLASMIN". The FDA issued a decision of Substantially Equivalent on March 16, 2006. The device falls under product code DDB (Ceruloplasmin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5210. Dade Behring, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 16, 2006
Date Received
November 1, 2005
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Ceruloplasmin, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5210
Review Panel
IM
Submission Type